Joung-Soon Jang

418 total citations
11 papers, 240 citations indexed

About

Joung-Soon Jang is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Joung-Soon Jang has authored 11 papers receiving a total of 240 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Joung-Soon Jang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Joung-Soon Jang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Lung Cancer Research Studies (4 papers) and Lung Cancer Treatments and Mutations (3 papers). Joung-Soon Jang collaborates with scholars based in South Korea and United States. Joung-Soon Jang's co-authors include In Gyu Hwang, Ho Yeong Lim, Jung Hun Kang, Sung Yong Oh, Kyung Hee Lee, Hong Song, Jae Ho Byun, Yeul Hong Kim, Myung Ah Lee and Sang Cheul Oh and has published in prestigious journals such as British Journal of Cancer, World Journal of Gastroenterology and The Oncologist.

In The Last Decade

Joung-Soon Jang

11 papers receiving 233 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joung-Soon Jang South Korea	10	136	122	105	38	28	11	240
Nobuyuki Ohashi Japan	9	101 0.7×	57 0.5×	22 0.2×	44 1.2×	23 0.8×	35	235
Niharika Mallepally United States	8	167 1.2×	66 0.5×	89 0.8×	72 1.9×	10 0.4×	19	302
S. Marmor Israel	9	90 0.7×	98 0.8×	54 0.5×	66 1.7×	18 0.6×	19	245
M. Cobo Spain	8	199 1.5×	215 1.8×	93 0.9×	27 0.7×	9 0.3×	20	342
Austin Taylor United States	7	62 0.5×	56 0.5×	35 0.3×	23 0.6×	41 1.5×	16	403
Harkirat Singh United States	7	204 1.5×	62 0.5×	132 1.3×	46 1.2×	5 0.2×	22	294
Louise Bondeelle France	9	45 0.3×	103 0.8×	50 0.5×	45 1.2×	8 0.3×	21	193
Masaki Taruishi Japan	8	170 1.3×	193 1.6×	127 1.2×	45 1.2×	9 0.3×	22	338
Jennifer A. Yonkus United States	9	122 0.9×	59 0.5×	76 0.7×	55 1.4×	3 0.1×	32	206
Katjana Schwab Germany	12	142 1.0×	53 0.4×	32 0.3×	32 0.8×	8 0.3×	23	285

Countries citing papers authored by Joung-Soon Jang

Since Specialization

Citations

This map shows the geographic impact of Joung-Soon Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joung-Soon Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joung-Soon Jang more than expected).

Fields of papers citing papers by Joung-Soon Jang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joung-Soon Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joung-Soon Jang. The network helps show where Joung-Soon Jang may publish in the future.

Co-authorship network of co-authors of Joung-Soon Jang

This figure shows the co-authorship network connecting the top 25 collaborators of Joung-Soon Jang. A scholar is included among the top collaborators of Joung-Soon Jang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joung-Soon Jang. Joung-Soon Jang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Kang, Jin Hyoung, Dong‐Wan Kim, Sang-We Kim, et al.. (2020). A randomised phase 2b study comparing the efficacy and safety of belotecan vs. topotecan as monotherapy for sensitive-relapsed small-cell lung cancer. British Journal of Cancer. 124(4). 713–720. 18 indexed citations

Lee, Yun‐Gyoo, Ju Hyun Lee, Se Hyun Kim, et al.. (2018). Comparative analysis between combination and single-agent chemotherapy for elderly patients with advanced non-small cell lung cancer: A nationwide population-based outcome study. Lung Cancer. 122. 88–93. 6 indexed citations

Jang, Joung-Soon, Hoon-Kyo Kim, Byoung Chul Cho, et al.. (2017). Randomized phase II study comparing weekly docetaxel-cisplatin vs. gemcitabine-cisplatin in elderly or poor performance status patients with advanced non-small cell lung cancer. Cancer Chemotherapy and Pharmacology. 79(5). 873–880. 12 indexed citations

Go, Se‐Il, Dong‐Hoe Koo, Seung Tae Kim, et al.. (2017). Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial. The Oncologist. 22(11). 1354–1361. 22 indexed citations

Kim, Jeong Eun, Joung-Soon Jang, Jae‐Weon Kim, et al.. (2016). Efficacy and safety of aprepitant for the prevention of chemotherapy-induced nausea and vomiting during the first cycle of moderately emetogenic chemotherapy in Korean patients with a broad range of tumor types. Supportive Care in Cancer. 25(3). 801–809. 9 indexed citations

Hwang, In Gyu, Jung Hun Kang, Sung Yong Oh, et al.. (2015). Phase II trial of epidermal growth factor ointment for patients with Erlotinib-related skin effects. Supportive Care in Cancer. 24(1). 301–309. 9 indexed citations

Hwang, In Gyu, Joung-Soon Jang, Sung Yong Oh, et al.. (2015). Phase II study of mFOLFOX3 (5-fluorouracil, leucovorin, oxaliplatin) as second-line treatment after gemcitabine failure in patients with unresectable/metastatic biliary tract cancer. Cancer Chemotherapy and Pharmacology. 75(4). 757–762. 11 indexed citations

Lee, Min Jeong, In Gyu Hwang, Joung-Soon Jang, et al.. (2012). Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies. Cancer Research and Treatment. 44(4). 235–241. 21 indexed citations

Lee, Dong‐Gun, Sung‐Han Kim, Soo Young Kim, et al.. (2011). Evidence-based Guidelines for Empirical Therapy of Neutropenic Fever in Korea. Infection and Chemotherapy. 43(4). 258–258. 33 indexed citations

10.

Jang, Joung-Soon, Ho Yeong Lim, In Gyu Hwang, et al.. (2009). Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial. Cancer Chemotherapy and Pharmacology. 65(4). 641–647. 57 indexed citations

11.

Oh, Sung Yong, Su Jin Lee, Jeeyun Lee, et al.. (2009). Gastric leptomeningeal carcinomatosis: Multi-center retrospective analysis of 54 cases. World Journal of Gastroenterology. 15(40). 5086–5086. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact